Abstract
Aminoglycosides are known to cause oxidative stress related toxicities and tissue injuries. Present study was planned to evaluate the effect of aminoglycosides on blood oxidative stress parameters in mice and free radical scavenging potential of cephalosporins, when combined as a single injection with aminoglycosides using chemical vector mediated technology. Mus musculus mice were divided into five groups: Control group animals (treated with normal saline), amikacin treated group, tobramycin treated group, cefepime + amikacin treated group and ceftazidime + tobramycin treated group. A significant improvement in superoxide dismutase (SOD), catalase activities, along with malonaldialdehyde (MDA) levels and creatinine levels were observed in fixed dose combination of cephalosporins and aminoglycosides treated groups as compared to aminoglycosides alone (amikacin and tobramycin) treated groups. These findings indicate that on combining cephalosporins with aminoglycosides using chemical vector mediated technology prevents oxidative stress related tissues injury induced by aminoglycosides.
Keywords: Cephalosporin, aminoglycoside, free radicals, catalase, superoxide dismutase, malonaldialdehyde
Current Drug Therapy
Title: Anti Oxidant Property of New Cephalosporin-Aminoglycoside Fixed Dose Combination
Volume: 4 Issue: 1
Author(s): Manu Chaudhary, Arvind Soni, Vivek Kumar Dwivedi and Rajesh Sehgal
Affiliation:
Keywords: Cephalosporin, aminoglycoside, free radicals, catalase, superoxide dismutase, malonaldialdehyde
Abstract: Aminoglycosides are known to cause oxidative stress related toxicities and tissue injuries. Present study was planned to evaluate the effect of aminoglycosides on blood oxidative stress parameters in mice and free radical scavenging potential of cephalosporins, when combined as a single injection with aminoglycosides using chemical vector mediated technology. Mus musculus mice were divided into five groups: Control group animals (treated with normal saline), amikacin treated group, tobramycin treated group, cefepime + amikacin treated group and ceftazidime + tobramycin treated group. A significant improvement in superoxide dismutase (SOD), catalase activities, along with malonaldialdehyde (MDA) levels and creatinine levels were observed in fixed dose combination of cephalosporins and aminoglycosides treated groups as compared to aminoglycosides alone (amikacin and tobramycin) treated groups. These findings indicate that on combining cephalosporins with aminoglycosides using chemical vector mediated technology prevents oxidative stress related tissues injury induced by aminoglycosides.
Export Options
About this article
Cite this article as:
Chaudhary Manu, Soni Arvind, Dwivedi Kumar Vivek and Sehgal Rajesh, Anti Oxidant Property of New Cephalosporin-Aminoglycoside Fixed Dose Combination, Current Drug Therapy 2009; 4(1) . https://dx.doi.org/10.2174/157488509787081877
DOI https://dx.doi.org/10.2174/157488509787081877 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Why Should We Keep the Cerebellum in Mind When Thinking About Addiction?
Current Drug Abuse Reviews IL-37 As a Potential Biotherapeutics of Inflammatory Diseases
Current Drug Targets Vital Elements of the Wnt-Frizzled Signaling Pathway in the Nervous System
Current Neurovascular Research Long-term Potentiation at Spinal C-fiber Synapses: A Target for Pathological Pain
Current Pharmaceutical Design New Cathepsin D Inhibitorswith Hydroxyethylamine Isosteres: Preparation and Characterization
Medicinal Chemistry A Role of the Parasympathetic Nervous System in Cognitive Training
Current Alzheimer Research Conference Report: 184th American Association for the Advancement of Science Annual Meeting, Austin TX, USA Feb. 15-19, 2018
CNS & Neurological Disorders - Drug Targets Novel Thioester Prodrug of N-acetylcysteine for Odor Masking and Bioavailability Enhancement
Current Drug Delivery Dynamics of Diabetes and Obesity: An Alarming Situation in the Developing Countries in Asia
Mini-Reviews in Medicinal Chemistry Thromboxane A<sub>2</sub> Receptor Polymorphism in Association with Cerebral Infarction and its Regulation on Platelet Function
Current Neurovascular Research The Role of MRI and PET/SPECT in Alzheimers Disease
Current Topics in Medicinal Chemistry Aberrant Expression of MicroRNAs in B-cell Lymphomas
MicroRNA Interleukin-26, An Epitheliotropic T-Cell Cytokine
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry <i>LncRNA</i> Xist, X-chromosome Instability and Alzheimer’s Disease
Current Alzheimer Research Chemistry and Biology of Indoles and Indazoles: A Mini-Review
Mini-Reviews in Medicinal Chemistry Snake Venom: From Deadly Toxins to Life-saving Therapeutics
Current Medicinal Chemistry NO Chimeras as Therapeutic Agents in Alzheimers Disease
Current Alzheimer Research Natural Quinones: Antioxidant and Antiaggregant Action Towards Glyceraldehyde-3-Phosphate Dehydrogenase
Current Organic Chemistry Critical Review of Malondialdehyde Analysis in Biological Samples
Current Pharmaceutical Analysis Integrated Biomarkers for Depression in Alzheimer’s Disease: A Critical Review
Current Alzheimer Research